| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A deep dive into the darning effects of biomaterials in infarct myocardium: current advances and future perspectives
|
Hemalatha, Thiagarajan
|
|
|
27 |
4 |
p. 1443-1467
|
artikel
|
| 2 |
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 2020
|
Guglin, Maya
|
|
|
27 |
4 |
p. 1341-1353
|
artikel
|
| 3 |
Cognitive impairment in heart failure: clinical implications, tools of assessment, and therapeutic considerations
|
Liori, Sotiria
|
|
|
27 |
4 |
p. 993-999
|
artikel
|
| 4 |
Current and emerging drug targets in heart failure treatment
|
Ghionzoli, Nicolò
|
|
|
27 |
4 |
p. 1119-1136
|
artikel
|
| 5 |
Deciphering hypertrophic cardiomyopathy with electrocardiography
|
Gossios, Thomas
|
|
|
27 |
4 |
p. 1313-1323
|
artikel
|
| 6 |
Dependence and reduced motor function in heart failure: future directions for well-being
|
Hibino, Hidetaka
|
|
|
27 |
4 |
p. 1043-1051
|
artikel
|
| 7 |
Diagnosis of cardiac sarcoidosis: a primer for non-imagers
|
Agrawal, Tanushree
|
|
|
27 |
4 |
p. 1223-1233
|
artikel
|
| 8 |
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments
|
Orphanou, Nicoletta
|
|
|
27 |
4 |
p. 1173-1191
|
artikel
|
| 9 |
Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials
|
Ghizzardi, Greta
|
|
|
27 |
4 |
p. 1029-1041
|
artikel
|
| 10 |
Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers
|
Xiang, Kun
|
|
|
27 |
4 |
p. 1211-1221
|
artikel
|
| 11 |
Filamin C in cardiomyopathy: from physiological roles to DNA variants
|
Song, Shen
|
|
|
27 |
4 |
p. 1373-1385
|
artikel
|
| 12 |
Functional tricuspid regurgitation, related right heart remodeling, and available treatment options: good news for patients with heart failure?
|
Tadic, Marijana
|
|
|
27 |
4 |
p. 1301-1312
|
artikel
|
| 13 |
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions
|
Tsigkas, Grigorios
|
|
|
27 |
4 |
p. 1201-1210
|
artikel
|
| 14 |
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement
|
Dandel, Michael
|
|
|
27 |
4 |
p. 1325-1339
|
artikel
|
| 15 |
Histamine receptors in heart failure
|
Levick, Scott P.
|
|
|
27 |
4 |
p. 1355-1372
|
artikel
|
| 16 |
Minimally invasive versus conventional continuous-flow left ventricular assist device implantation for heart failure: a meta-analysis
|
Zhang, Bufan
|
|
|
27 |
4 |
p. 1053-1061
|
artikel
|
| 17 |
Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress
|
Li, Aoxue
|
|
|
27 |
4 |
p. 1387-1394
|
artikel
|
| 18 |
Multiple roles of cardiac macrophages in heart homeostasis and failure
|
Moskalik, Aneta
|
|
|
27 |
4 |
p. 1413-1430
|
artikel
|
| 19 |
New antidiabetic therapy and HFpEF: light at the end of tunnel?
|
Tadic, Marijana
|
|
|
27 |
4 |
p. 1137-1146
|
artikel
|
| 20 |
New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy
|
Yang, Jingmin
|
|
|
27 |
4 |
p. 1431-1441
|
artikel
|
| 21 |
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
|
Dutka, Mieczysław
|
|
|
27 |
4 |
p. 1395-1411
|
artikel
|
| 22 |
Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?
|
Correale, Michele
|
|
|
27 |
4 |
p. 1147-1163
|
artikel
|
| 23 |
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
|
Hajduczok, Alexander G.
|
|
|
27 |
4 |
p. 1281-1300
|
artikel
|
| 24 |
Response to letter to the editor regarding the article “SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis” Cardiac, renal protection with SGLT2 inhibitors is evident but not in every diabetic patient
|
Barbarawi, Mahmoud
|
|
|
27 |
4 |
p. 1469
|
artikel
|
| 25 |
Right ventricular diastolic dysfunction and failure: a review
|
Jung, Youn-Hoa
|
|
|
27 |
4 |
p. 1077-1090
|
artikel
|
| 26 |
Risk stratification in cardiogenic shock: a focus on the available evidence
|
Sciaccaluga, C.
|
|
|
27 |
4 |
p. 1105-1117
|
artikel
|
| 27 |
Sedentary behavior and health outcomes in patients with heart failure: a systematic review and meta-analysis
|
Zhao, Qiuge
|
|
|
27 |
4 |
p. 1017-1028
|
artikel
|
| 28 |
Social and environmental risks as contributors to the clinical course of heart failure
|
Narita, Koichi
|
|
|
27 |
4 |
p. 1001-1016
|
artikel
|
| 29 |
Speckle tracking echocardiography in primary mitral regurgitation: should we reconsider the time for intervention?
|
Pastore, Maria Concetta
|
|
|
27 |
4 |
p. 1247-1260
|
artikel
|
| 30 |
Subclinical cardiac damage in cancer patients before chemotherapy
|
Fabiani, Iacopo
|
|
|
27 |
4 |
p. 1091-1104
|
artikel
|
| 31 |
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications
|
Abawi, Dawud
|
|
|
27 |
4 |
p. 1261-1279
|
artikel
|
| 32 |
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction
|
Aimo, Alberto
|
|
|
27 |
4 |
p. 1165-1171
|
artikel
|
| 33 |
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences
|
Sciaccaluga, C
|
|
|
27 |
4 |
p. 1235-1246
|
artikel
|
| 34 |
Transcatheter therapies for secondary mitral regurgitation in advanced heart failure: what are we aiming for?
|
Scotti, Andrea
|
|
|
27 |
4 |
p. 1193-1200
|
artikel
|
| 35 |
Ventricular non-compaction review
|
Srivastava, Shaurya
|
|
|
27 |
4 |
p. 1063-1076
|
artikel
|
Tijdschrift beschrijving